Page last updated: 2024-12-09
lithium bis(trimethylsilyl)amide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
lithium bis(trimethylsilyl)amide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 2733832 |
| SCHEMBL ID | 6240 |
| MeSH ID | M0402204 |
Synonyms (112)
| Synonym |
|---|
| rc4n1i108m , |
| lithiumbis(trimethylsilyl)amide |
| lithium, (bis(trimethylsilyl)amino)- |
| disilazane, 1,1,1,3,3,3-hexamethyl-, lithium salt |
| ec 223-725-6 |
| silanamine, 1,1,1-trimethyl-n-(trimethylsilyl)-, lithium salt |
| einecs 223-725-6 |
| unii-rc4n1i108m |
| silanamine, 1,1,1-trimethyl-n-(trimethylsilyl)-, lithium salt (1:1) |
| nsc 252161 |
| 4039-32-1 |
| lithium bis(trimethylsilyl)amide |
| bis(trimethylsilyl)amido lithium |
| hexamethyldisilazane lithium salt |
| n-lithiohexamethyldisilazane |
| lithium bis(trimethylsilyl)amide, 97% |
| lithium bis-(trimethylsilyl)amide |
| lihmds |
| H0915 |
| lhmds |
| lithium hexamethyldisilazide |
| lithium bis(trimethylsilyl)azanide |
| A825085 |
| AKOS015967096 |
| S09630 |
| hexamethyldisilazane lithium salt 1m in thf |
| BP-13374 |
| FT-0605921 |
| AKOS015909050 |
| lithium bis(trimethylsilyl)amine |
| SCHEMBL6240 |
| lithium bis(trimethyl-silyl)amide |
| lithium bis(tms) amide |
| lithium hexamethyldisilazid |
| lin(tms)2 |
| lithium bis(tri-methylsilyl)amide |
| lithium bis(trimethyl silyl)amide |
| lithium bis trimethylsilyl amide |
| lithium bis(trimethylsilyl)-amide |
| lithium hexamethydisilazide |
| lithium bis (trimethylsilyl) amide |
| lithium hexamethlydisilazide |
| lithium bis trimethylsilylamide |
| lithiumhexamethyl disilazide |
| lithium bis(trimethylsily)amide |
| lithium bis(trimethyl silyl)-amide |
| lithium bis(trimethylsilyl)amid |
| lithiumbistrimethylsilylamide |
| lithium hexamethyl-disilazide |
| lithiohexamethyldisilazane |
| lithium hexa methyl disilazide |
| YNESATAKKCNGOF-UHFFFAOYSA-N |
| bis(trimethylsilyl)aminolithium |
| lithium bis(trimethylsilyl) azanide |
| lin(sime3)2 |
| lithium bis(trimethlsilyl)amide |
| lithium bis(trimethysilyl) amide |
| lithium bis(trimethylsilyl) amide |
| lithium hexamethyl disilazide |
| lithium bis(trimethylsilyl)arnide |
| lithium bis (trimethylsilyl)amide |
| lithium bis-(trimethylsilyl) amide |
| lithium hexamethyldisilazanide |
| lithium bis(trimethlysilyl)amide |
| lithium bis[trimethylsilyl]amide |
| lithium bis(trimethysilyl)amide |
| n-lithio-hexamethyldisilazane |
| (bis(trimethylsilyl)amino)lithium |
| lithiumhexamethyldisilazide |
| (bis(trimethylsilyl)amino) lithium |
| lithiumbistrimethylsilyl amide |
| lithium bistrimethylsilyl amide |
| lithium bis-trimethysilylamide |
| lithium 1, 1, 1, 3,3,3-hexamethyldisilazan-2-ide |
| bis(trimethylsilyl)amide lithium |
| lithium hexamethyidisilazide |
| lithiumhexamethyidisilazide |
| lithium bis(trimethyl- silyl)amide |
| lithium n,n-bistrimethylsilylamide |
| lithium 1,1,1,3,3,3-hexamethyldisilazan-2-ide |
| DTXSID2044426 |
| lithium bistrimethylsilylamide |
| lithium bis-(trimethylsilyl)-amide |
| lithium bis-trimethylsilylamide |
| J-640310 |
| lithium hexamethyldisilazanate |
| n,n-bis(trimethylsilyl)amine lithium salt |
| lithiobis(trimethylsilyl)amide |
| 1,1,1,3,3,3-hexamethyldisilazane lithium salt |
| (hexamethyldisilazane)lithium |
| 1,1,1-trimethyl-n-(trimethylsilyl)silanamine lithium salt |
| (1,1,1-trimethyl-n-(trimethylsilyl)silanaminato)lithium |
| lithium bis(trimethylsilyl)amide, 1m in toluene |
| lithium bis(trimethylsilyl)amide, 20%, ca 1.06m in thf/eb |
| lithium bis(trimethylsilyl)amide, 0.9-1.1m in hexane, packaged in resealable chemseal bottles |
| J-802235 |
| phenylmethyl carbonate |
| J-800313 |
| lithium bis(trimethylsilyl)amide, 1m in tetrahydrofuran |
| mfcd00008261 |
| hexamethyldisilazane lithium salt 1.25m (23-25%) in thf |
| lithium hexamethyldisilazide;lihmds |
| BCP21718 |
| lithium;bis(trimethylsilyl)azanide |
| Q219037 |
| lithium bis(trimethylsilyl)amide (ca. 26% in tetrahydrofuran, ca. 1.3mol/l) |
| AMY39452 |
| lithiobis(trimethylsilyl)amide; lithiohexamethyldisilazane; lithium bis(trimethylsilyl)amide; lithium bis(trimethylsilyl)amide(1-) |
| AT25133 |
| lithium hexamethyldisilazide, 0.85m in hexane (19-21 wt %) |
| lithiumhexamethyldisilazide1mintetrahydrofuran |
| lithium hexamethyldisilazide, 1.25m in tetrahydrofuran (23-25 wt %) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (25)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (56.00) | 29.6817 |
| 2010's | 9 (36.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 61.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (61.75) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 25 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||